SGMO Company Profile and Key Details
Sangamo Therapeutics, Inc.
SGMO Stock Price Chart
Stock Price Today
Sangamo Therapeutics, Inc. (SGMO) stock surged +5.98%, trading at $1.24 on NASDAQ, up from the previous close of $1.17. The stock opened at $1.17, fluctuating between $1.15 and $1.25 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
Brisbane California, CALIFORNIA 94005
United States
Website: https://www.sangamo.comContact: 510 970 6000About Company
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucleases, which are proteins used in modifying DNA sequences by adding or knocking out specific genes; and ZFP transcription factors proteins used in increasing or decreasing gene expression. It develops SB-525, which is in Phase III AFFINE clinical trial for the treatment of hemophilia A; ST-920, a gene therapy, which is in Phase I/II STAAR clinical trials for the treatment of Fabry disease; and SAR445136, a cell therapy, which is in Phase I/II PRECIZN-1 clinical trials for the treatment of sickle cell disease. The company also develops TX200, chimeric antigen receptor for the treatment of HLA-A2 mismatched kidney transplant rejection; KITE-037, a cell therapy for the treatment of cancer; ST-501 for the treatment of tauopathies; and ST-502 for the treatment of synucleinopathies, including Parkinson's disease and neuromuscular disease. It has collaborative and strategic partnerships with Biogen MA, Inc.; Kite Pharma, Inc.; Pfizer Inc.; Sanofi S.A.; Novartis Institutes for BioMedical Research, Inc.; Shire International GmbH; Dow AgroSciences LLC; Sigma-Aldrich Corporation; Genentech, Inc.; Open Monoclonal Technology, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and California Institute for Regenerative Medicine. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Sangamo Therapeutics, Inc. was incorporated in 1995 and is headquartered in Brisbane, California.
Company Information
| Employees | 405 |
| Beta | 1.1 |
| Sales or Revenue | $176.23M |
| 5Y Sales Change% | 0.16% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) stock price is $1.24 in the last trading session. During the trading session, SGMO stock reached the peak price of $1.25 while $1.15 was the lowest point it dropped to. The percentage change in SGMO stock occurred in the recent session was 5.98% while the dollar amount for the price change in SGMO stock was $0.07.
The NASDAQ listed SGMO is part of Biotechnology industry that operates in the broader Healthcare sector. Sangamo Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Jaspreet Gill
Chief Quality Officer
Ms. Prathyusha Duraibabu CPA, M.B.A.
Senior Vice President, Chief Financial Officer & Principal Accounting Officer
Mr. Scott B. Willoughby
Senior Vice President, Gen. Counsel & Corporation Sec.
Phillip Ramsey
Head of Technical Operations
Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.
Chief Executive Officer, Pres & Director
Mr. D. Mark McClung
Chief Operating Officer
Ms. Heather Erickson
Chief of Staff
Dr. Nathalie Dubois-Stringfellow Ph.D.
Senior Vice President & Chief Devel. Officer
Ms. Whitney Jones
Chief People Officer
Dr. Jason D. Fontenot Ph.D.
Chief Scientific Officer
Dr. R. Andrew Ramelmeier Ph.D.
Executive Vice President of Technical Operations
Ms. Prathyusha Duraibabu C.P.A., M.B.A.
Senior Vice President, Chief Financial Officer & Principal Accounting Officer
Dr. Bettina M. Cockroft M.B.A., M.D.
Chief Medical Officer
Dr. Lisa Rojkjaer M.D.
Chief Medical Officer
Ms. Aron Feingold
Vice President of Investor Relations & Corporation Communications
SGMO's closing price is 313.33% higher than its 52-week low of $0.30 where as its distance from 52-week high of $3.18 is -61.01%.
Number of SGMO employees currently stands at 405.
Official Website of SGMO is: https://www.sangamo.com
SGMO could be contacted at phone 510 970 6000 and can also be accessed through its website. SGMO operates from 501 Canal Blvd, Brisbane California, CALIFORNIA 94005, United States.
SGMO stock volume for the day was 2.59M shares. The average number of SGMO shares traded daily for last 3 months was 7.8M.
The market value of SGMO currently stands at $258.72M with its latest stock price at $1.24 and 208.65M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com